Standout Papers
Citation Impact
Citing Papers
Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features
1998
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma
2012
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
2012
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
2014
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
2001
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
2015
The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection
1997
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Epidemiology of Hepatocellular Carcinoma
2013
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
International trends and patterns of primary liver cancer
2001
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
2010
Semiannual and Annual Surveillance of Cirrhotic Patients for Hepatocellular Carcinoma: Effects on Cancer Stage and Patient Survival (Italian Experience)
2002
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma
2011
Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10–20 mm) detected in the cirrhotic liver at screening ultrasound
2017
Is tumor biopsy necessary?
2011
Small (≤1-cm) Hepatocellular Carcinoma: Diagnostic Performance and Imaging Features at Gadoxetic Acid–enhanced MR Imaging
2014
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
1999
Hepatocellular carcinoma
2012 Standout
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
2010
Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2cm
2014
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
2023
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging
2015
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study
2013
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Clinical relevance of hepatitis C virus genotypes.
1997
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
2008
Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques
2010
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
2018
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 Standout
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
1997
Non-alcoholic fatty liver disease
2021 Standout
Retransplantation in patients with hepatitis C recurrence after liver transplantation
2010
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
2010
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus
2003
Liver transplantation and hepatitis C
2011
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US
2015
Screening for hepatocellular carcinoma in cirrhosis
2003
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
2003
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma
2015
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Hepatitis C and hepatocellular carcinoma
1997
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016
Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
2008
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
2001
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe
2001
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity
2001
Occult hepatitis B
2002
Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
1997
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none?
2010
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging
2012
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy
1997
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
2013
Hepatocellular Carcinoma
2011 Standout
Treatment of Hepatocellular Carcinoma
2016
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis
2015
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines
2011
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
2017
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Hepatocellular carcinoma
2022 Standout
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
A cis -Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication
2004 StandoutNobel
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
2014
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
2017
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
2002
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
2017
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
Impact of gadoxetic acid (Gd‐EOB ‐DTPA )‐enhanced magnetic resonance on the non‐invasive diagnosis of small hepatocellular carcinoma: a prospective study
2012
Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016
2017
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Surveillance for hepatocellular carcinoma
2014
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo
2000 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound
2013
Global cancer statistics, 2012
2015 Standout
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy
2011
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
2016
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Liver stiffness‐based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy
2016
Works of G. Ronchi being referenced
Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis
2002
Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection
1996
High Prevalence of Multinodular Hepatocellular Carcinoma in Patients With Cirrhosis Attributable to Multiple Risk Factors
1999
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation
2008
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease
2007
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
2009
Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma
1991 StandoutNobel
Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients.
1993
Gastric cancer in chronic atrophic gastritis. Associated gastric ulcer adds no further risk.
1987